COMPANY PROFILE. Beloura Office Park, Ed. 11 Quinta da Beloura Sintra PORTUGAL

Similar documents
Think. Create. Deliver. Skin Friendly Turn-Key Solutions

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

Healthcare and Life Sciences

Welcome to Althea. Welcome to the future of integrated healthcare technology management

Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

THE PILLARS THAT SUPPORT US

Epilogue. Simona Rocchi Erasmus University, Centre for Environmental Studies, Rotterdam

Roche in Mannheim. The high-tech campus

Model Based Design Of Medical Devices

pure. precise. perfect.

Corporate Mind 2016 Corporate Responsibility Report

Health & Social Care Industrial Innovation

A digital health age how to take on the challenges of this advancing field

WE MAKE RELATIONSHIP FOR LIFE.

Training Overview. Europe 2015

Fresenius Medical Care North America (FMCNA)

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Engineering & Tooling Industry

NEWS RELEASE. Life sciences companies tout their expertise in India

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

COUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550

Digital Medical Device Innovation: A Prescription for Business and IT Success

V I S I O N South Wolf Road, Wheeling, IL

HARTING Coaxial and Metric Connectors

YOUR PARTNER FOR CHALLENGING PROJECTS

2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award

experience knowledge innovation

THE JOSÉ DE MELLO GROUP

Medicines Manufacturing in the UK 2017

JOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed

Your partner for challenging projects

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Intellectual Property, Vaccine Production and Technology Transfer

MESSAGE FROM THE BOARD

HEALTH INNOVATION EXCHANGE

AMERICAN MADE. experience INNOVATION. We are American Made

Diagnosing the Success Formula for MedTech Companies in India

Mara H. Rogers, Partner Norton Rose Fulbright

THE SCIENTIFIC AND TECHNOLOGICAL PARK OF SENEGAL

the SPD company Dr Clive Simon, Principal, The SPD Company.

(Fig.) JPMA Industry Vision 2025

Koen Dejonckheere. Professional experience. Board Memberships. Education

About Us 3LAGSPA. Our Values:

Pharma Clean Assurance Programme.

Vision. We strive to be an accomplished business player in the region assuring superior value to all stakeholders.

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008

In the heart of Industrial electronics

Life Sciences Outlook. New York City 2016

Interview with Prof. Dr. Stefan Mecheels, CEO Hohenstein Institute in Bönnigheim (Germany)

LESJÖFORS FLAT SPRINGS. The Lesjöfors Group also includes.

Science and Technology Park

PEDRO METELLO DE NÁPOLES

Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

Turning the wheels of your success

CAPETANO OIL LIMITED (+233) (+233)

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

Omeros Raises More Than $63 Million in Financing

Institutional Presentation. July / 2017

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

An Essential Health and Biomedical R&D Treaty

SOLUTIONS WITH INSIGHT

+Architecture+ Design

Institutional Presentation

PROMOTING QUALITY AND STANDARDS

Draft Plan of Action Chair's Text Status 3 May 2008

IN-DEPTH ASSESSMENT OF THE SITUATION (CONTRACT NO ENTR/2010/16, LOT 2) Task 6: Research, Development and Innovation in the Footwear Sector

Metrology at NRC Canada: An NMI in an RTO Context

MEDICAL & LIFE SCIENCES

mission why join? our members

What is the role of a consultant. in the digital healthcare era?

Reflections on Innovation, Science, and Society

FOCUSED INNOVATIONS IN LIFE SCIENCES

WEGrow A success story: Geraldine Mlynarz Chilean high-growth woman entrepreneur

Using Academic Licensing Agreements to Promote Global Social Responsibility

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market

COMPANY PROFILE. About Us. Company Factsheet

A GLOBAL REACH MEDIA KIT

1. Protecting the work and expressing the potential of our clients' companies

Advanced solutions Medical, cosmetics and personal care. Name it. We ll do it.


Optime Subsea AS. Web: BIC/SWIFT: SPTRN022 IBAN: NO

Breathe, Think, Live air.

Corporate Mind 2015 Corporate Responsibility Report

From analysis to the future

New Regulatory Framework for Electronic Communications in Angola

Dynamics of National Systems of Innovation in Developing Countries and Transition Economies. Jean-Luc Bernard UNIDO Representative in Iran

The Current Market Scene of Hong Kong Medical and Healthcare Device Industries. Ir Prof Andros Chan Chairman - HKMHDIA

EDUCATION ON STANDARDS DEVELOPED BY A PUBLIC INSTITUTION OF BRAZIL TO PROMOTE COMPETITIVENESS OF INDUSTRY

INTERNATIONAL WINTER SCHOOL

Technology Leadership Course Descriptions

Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Boundaryless Hospital - Rethink and Redefine Health Care Management. New Chains of Value Creation

WELCOME TO THE WORLD OF LABORATORIES

The role of the technology platform «Medicine of the Future» in biomedical innovations development. Kurzina Irina 21 May 2014, Moscow

The IET Strategic Framework. Working to engineer a better world

Transcription:

COMPANY PROFILE www.quilaban.pt Beloura Office Park, Ed. 11 Quinta da Beloura 2710-693 Sintra PORTUGAL

MILESTONES Foundation of the company Vítor Hugo da Silva Cordeiro: - Wholesaler of medicines and cosmetics; - Owner of pharmacies. Widening the portfolio of the Orthopaedics business unit to healthcare consumables (OHC). Setup of Orthopaedics 1974 business unit 2005 2007 Quilaban, Lda. becomes Quilaban, S.A. 1940 2004 2010 2013 Creation of the company Quilaban, Lda., integrating the previous activities and starting: - Import and distribution of in vitro Diagnostics and Biotechnology Setup of Point-of-Care (POC) and Veterinary (VET) business units Setup of Export business unit and launch of activities in Angola Merging of the POC, VET and OHC business units into Healthcare business unit

MISSION MISSION, VISION AND VALUES MISSION TO GENERATE SUSTAINED ACCESS TO HEALTH CARE VALUE BY PROMOTING THE Our aim is to promote the access of our costumers to health care, through our distribution services and the supply of medicines as well as other health products.

MISSION MISSION, VISION AND VALUES VISION TO BE THE PREFERRED PARTNER IN THE DEVELOPMENT AND IMPLEMENTATION OF EFFICIENT, INTEGRATED AND INNOVATIVE SOLUTIONS, THAT PROMOTE THE ACCESS TO HEALTH CARE Our knowledge and experience in the health care markets, mainly in what concerns medicines supply combined with the proficiencies of our human resources and our strong culture of partnership, made us a reference in the market in what regards the access to health care. Innovation and efficiency are the focus elements in our company culture, allowing us to positively respond to the constant challenges presented to us in the market. We are compromised to our customers and committed in satisfying their needs, overcoming their expectations.

MISSION MISSION, VISION AND VALUES VALUES Partnership Promote the cooperation and integration of competences through partnerships built upon trustful, wide and transparent relationships. Efficiency We are very rigorous in the allocation of our resources, so they can be as cost effective as possible. Innovation Innovation is a key feature of our culture, making us creative and unique in our approaches and in the solutions we present. Service We serve passionate, and in a consistent and determined way all of our customers, complying with our promises. Simplicity We develop simple solutions relationship with our partners. Quality We are committed to a continuous references high standard levels of quality. and promote an easy improvement, having as

CERTIFICATION QUALITY NP EN ISO 9001:2000 since June 2005 by IQNet and APCER; Renovation of the certificate under the new norm NP 9001:2008 since March 2009; EN ISO FINANTIAL PME Leader Status since 2009. National ranking nº 156 (2013): awards small-medium sized companies according to their standard of excellence and risk profile.

HOW ARE WE ORGANIZED? Human Resources Headcount: 85 36 in Sales and Marketing 4 Service Engineers All the sales force have a degree in life sciences (pharmacists, biologists, biochemists, biotechnology engineers) Training and continuous education is privileged More than 390 automated instruments of different types and origins, installed all over the country in the Diagnostics area and more than 920 instruments installed in the POC/VET area. Infrastructure Headquarter: Beloura (Sintra) in Quilaban s own building Warehouses: 2500 m 2 Warehouse for: medicines, reagents, orthopaedics and healthcare products 3 cold units: 2ºC-8ºC; -20ºC; -80ºC

HOW ARE WE ORGANIZED? PHARMA EXPORT DIAGNOSTICS HEALTHCARE (POINT-OF-CARE + ORTHO-HEALTHCARE) BUSINESS UNITS

TURNOVER TRENDS TURNOVER IN M 35 30 25 20 18,159 (+79%) 20,691 (+14%) 31,549 (+11%) 28,445 (+18%) 24,009 (+18%) 20,36 (-2%) 15 10,150 (+28%) 10 7,934 5 0 2006 2007 2008 2009 2010 2011 2012 2013

DIAGNOSTICS CLINICAL DIAGNOSTICS AND RESEARCH Microbiologia Molecular Biology Immunology Parasitology Serology Virology Others Public (>85%) Hospitals Research / Education Others CUSTOMER SEGMENTATION Clinical Laboratories Private (<15%) Industry Others

MOLECULAR BIOLOGY DIAGNOSTICS PARTNERS MICROBIOLOGY

DIAGNOSTICS PARTNERS RAPID TESTING OTHER IMMUNOLOGY AUTOIMMUNITY SEROLOGY

HEALTHCARE POINT-OF-CARE PARTNERS BIOCHEMISTRY SKIN ANALYSIS RAPID TESTING POC Equipments for blood analysis : Biochemical parameters as: Lipid Profile, Haemoglobin, Erythrocytes, Oxidative Stress, Glucose - - etc.; PSA, MAU and Glycated Hemoglobin; Urine Analysis. Equipments for skin and hair analysis, to help performing the correct diagnosis and most effective advice of beauty products. Pregnancy tests; Several rapid tests (drugs of abuse, fecal occult blood, H. pylori, etc.).

HEALTHCARE MATERIALS HEALTHCARE ORTHO-HEALTHCARE PARTNERS In 2010 we created a new business unit called Healthcare, includes all kinds of Medical Disposables. The products have our own brand, called Q-Health. This new sector includes a wide range of quality products that Application area: Dressing materials and wound care; Incontinence products; Syringes, needles and catheters; Materials for sterilization; Surgical Instruments; Cellulose disposables; Measuring Instruments; Probes, cannulas and catheters; Disposable clothing; Diagnostic disposables.

HEALTHCARE ORTHO-HEALTHCARE PARTNERS ORTHOPAEDIC MATERIALS Quilaban offers an attractive portfolio of orthopaedic products, through exclusive distribution agreements for theportuguese market with the following companies/brands: Supports and rehabilitation products Thermal and antiseptic products Antidecubitus protection products Technical Aids In 2005, Quilaban created a facility for the construction of orthoprosthesis, within the premises of the company. In this facility, specialized technicians execute prosthesis for the hospital as well as for the private customer.

PHARMA In 2013, we created a new project in the Pharmaceutical Group representing 11 pharmacies of the Lisbon area. area Praxis The main goals are: To monitor and develop Marketing and Commercial strategies, in partnership with the Pharmaceutical Industry; Market Expansion by positioning these Pharmacies as a reference within the pharmaceutical Portuguese market; To promote an easy and safe access to medicines and other healthcare products.

EXPORT In 2007 Quilaban started the Export operations to Angola. Nowadays we have extended the distribution to other portuguese-speaking countries, namely Mozambique. We focus on building partnerships with our customers in every market we operate in, assuming commitments and overcoming expectations, providing a wide offer of: Diagnostics, Biotechnology and Healthcare solutions; Medicines (including injectable drug, psychotropic drug and cold-chain products) With an extended logistic knowledge, we can work as a facilitator for exports from Portugal. Aware of customers needs, we seek for new solutions and we also intend to meet those needs timely.

INTERNATIONALPRESENCE We are present in Portugal, Angola and Mozambique as a wholesaler for medicines, diagnostics, healthcare and orthopaedicus. Our company in India supports the sourcing for Quilaban, facilitating our relationship with our business partners locally. India

ANGOLA AUSTRALPHARMA Company Name: AustralPharma, Sociedade de Distribuição Produtos Farmacêuticos, S.A.R.L. de Date of establishment: 2007 Location: Luanda, Angola Business Type: Wholesaler Products/Services: Medicines; Orthopaedics; Diagnostic; Point-of-care; Medical Disposables and Instruments; Laboratory Equipment and Accessories Clients: Pharmacies (public and private) Clinics, Hospitals, Private Laboratories and Wholesalers Headcount: 36 Geographic range: Luanda, Benguela, Huambo, Cabinda, Malange, Uige

AUSTRALPHARMA BUSINESS MODEL REFERENCE PARTNER FOR HEALTHCARE IN ANGOLA Quilaban s negotiation capacity and extensive experience ensures that AustralPharma receives high quality products at competitive prices Quality products at competitive prices A team of 3 sales representatives develop their activity in the field, visiting costumers, promoting products and services in Luanda and also in other Provincies: Benguela, Huambo, Cabinda Partner in the Health Sector in Angola Competent Sales Force AustralPharma is seen as a partner by our costumers (ex: trainings) Increased levels of Costumes service AustralPharma is recognized in the Angolan market for the high level of service it provides to its Clients: quick answers to requests; product availability; proposals follow-up, on time deliveries

AUSTRALPHARMA LOGISTIC CAPACITY AUSTRALPHARMA HAS A SIGNIFICANT LOGISTIC CAPACITY Luanda warehouse 344 m 2 Zango warehouse 1060 m 2

ANGOLA Q-PHARMA We are starting a new company in Angola - Q-Pharma, beginning its activities in 2014, which will manage the distribution of pharmaceutical products, mainly sourced from India, targeting: Public Tenders Non- European Medicines Market Price sensitive markets

ANGOLA TECNOSAÚDE Company Name: Tecnosaúde - Formação e Consultoria Date of establishment: 2012 Location: Luanda, Angola Business Type: Training and Consultancy Company which operates in the healthcare sector, specifically in the pharmaceutical industry, providing services in Angola: Management and Human Resources Consultancy Technical and Scientific areas Pharmaceutical Management Behavioral Marketing Training Support to the Pharmaceutical Industry

MOZAMBIQUE MDS Company Name: MDS, Medicamentos e Diagnóstico na Saúde Date of establishment : 2013 Location: Maputo, Mozambique Business Type: Wholesaler Products/Services: Medicines; Orthopaedicus; Diagnostics; Point-of-care; Medical Disposables and Instruments; Laboratory Equipment and Accessories Headcount: 7 (initial staff) Start of sales in 2014.

YOUR TRUSTFUL PARTNER IN HEALTH MDS MISSION AND VALUES Reference partner on the Health Market concerning: Logistics and supply of medicines and health products; Training for Health Professionals; Pharmaceutical Management and Consultancy. High Quality Products Short Delivery time Competitive pricing Customer s continuous follow-up care EFFICACY EFFICIENCY PROXIMITY INNOVATION PROACTIVITY DYNAMISM

INDIA QUILABAN PHARMA TRADING Company Name: Quilaban Pharma Trading Private Limited Date of Establishment : 2013 Location: Deonar, Mumbai Business Type: Sourcing. 100% subsidiary of Quilaban S.A. (Portugal) Potential partners on: Medicines, Vaccines, Diagnostics and Hospital Care

QUILABAN PHARMA MISSION, VISION AND PURPOSES TRADING TO MAKE QUALITY PRODUCTS AVAILABLE FOR ALL OUR MARKETS AT THE MOST AFFORDABLE PRICE To identify suitable sourcing partners in order to facilitate our business; To become first choice of manufacturers for Angola and Mozambique markets by providing quality service and maximizing the business; To facilitate manufacture through the value chain of business; To supply complete medicines and healthcare solutions to Quilaban. We have a dedicated office in Mumbai to facilitate the relationship with our partners in India, through the value chain regarding: - Communication; - Logistics; - Market updates; - Order execution.

QUILABAN KEY SUCESS FACTOR We are passionate about finding solutions to respond to our customers needs. Our success is our customers success.